Vesicare and Omnaris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vesicare (solifenacin succinate) and Omnaris (ciclesonide). Common drug interactions include diarrhoea among females and arthritis among males.

The phase IV clinical study analyzes what interactions people have when they take Vesicare and Omnaris. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.

On Jul, 18, 2026

30 people who take Vesicare and Omnaris together, and have interactions are studied.

What are the common drug interactions of Vesicare and Omnaris, by gender? *:

female:

Diarrhoea
Fatigue (feeling of tiredness)
Urinary tract infection
Drug ineffective
Fall
Pneumonia
Pain
Anaemia (lack of blood)
Arthropathy
Dizziness

male:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blood pressure increased
Pneumonia
Post procedural infection
Adverse drug reaction
Constipation
Fatigue (feeling of tiredness)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)

What are the common drug interactions of Vesicare and Omnaris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Headache (pain in head)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Back injury
Chest pain
Constipation
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dizziness
Dyspnoea (difficult or laboured respiration)
Facial paresis (weakness in facial muscle movement)

60+:

Diarrhoea
Fatigue (feeling of tiredness)
Haematuria (presence of blood in urine)
Hand deformity
Hypoaesthesia (reduced sense of touch or sensation)
Lung neoplasm malignant (cancer tumour of lung)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Peripheral swelling
Pleural effusion (water on the lungs)
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 23.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 23.33%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 20.00%
Thyroid Diseases: 5 people, 16.67%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 16.67%
Pain: 3 people, 10.00%
Apnea (temporary absence or cessation of breathing): 3 people, 10.00%
Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 6.67%
Rashes (redness): 2 people, 6.67%
Osteoporosis (bones weak and more likely to break): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Vesicare and Omnaris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously